Net shares · 365d
+817.7K
1.1M buy · 295.0K sell
Net value · 365d
$19.6M
$20.0M in · $391.6K out
Sentiment · 365d
Net buying
98% buying · 2% selling
Open-market trades · 365d
4
1.1M buy · 295.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
AKTS Buy·P
TenPercentOwner
$20.0M
1.1M sh · $18.00
Own +12%
-
HOWL Sell·S
TenPercentOwner · 10b5-1
$391.6K
295.0K sh · $1.33 avg · 3 lots
Own -5%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jan 12, 2026 | AKTS | Buy P | 1.1M | $20.0M |
| Nov 3, 2025 | HOWL | Sell S | 295.0K3 lots | $391.6K |
Buy Sell Non-market (grant · exercise · gift)
About MPM ONCOLOGY INNOVATIONS FUND LP
This profile aggregates every SEC Form 4 insider transaction reported by MPM ONCOLOGY INNOVATIONS FUND LP across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.